Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer chemotherapy and heterocyclic compounds.

M Kidwai1, R Venkataramanan, R Mohan

  • 1Department of Chemistry, University of Delhi, India. mkidwai@mantraonline.com

Current Medicinal Chemistry
|June 8, 2002
PubMed
Summary

This review details advances in cancer chemotherapy since 1940, focusing on how modifying heterocyclic organic compounds like pyrrole and pyrimidine enhances antitumor drug development for neoplastic diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrothermal approach to Co-Ni Layered Double hydroxide: high-performance electrode materials for energy storage devices.

iScience·2026
Same author

Efficient composite partnering of crab shell-derived chitosan with tin oxide for anticancer and other biomedical applications.

International journal of biological macromolecules·2025
Same author

A library of proton lineal energy spectra spanning the full range of clinically relevant energies.

Medical physics·2025
Same author

Cost-effective synthesis of zinc oxide/crab shell-derived chitosan nanocomposite: Insights into its biomedical applications.

International journal of biological macromolecules·2024
Same author

Structural, magnetic, electric and electrochemical studies on zinc doped magnesium ferrite nano particles - Sol-gel method.

Heliyon·2024
Same author

Outcomes and complications of Titanium elastic nailing for forearm bones fracture in children: our experience in a district general hospital in the United Kingdom.

Acta orthopaedica Belgica·2023

Area of Science:

  • Pharmacological research and medicinal chemistry
  • Oncology and cancer therapeutics

Background:

  • Significant progress in cancer treatment began post-1940 with the discovery of nitrogen mustard's antileukemic activity.
  • Neoplastic transformation is linked to genetic alterations and oncogene activation, driving rapid advancements in drug discovery and disease pathobiology.
  • Cancer chemotherapy is a specialized and established field, with ongoing efforts to optimize treatment strategies and patient support.

Purpose of the Study:

  • To provide an updated overview of modifications to antitumor compounds, specifically heterocyclic organic compounds.
  • To rationalize and organize information on heterocycles with promising cytotoxicity profiles for cancer treatment.

Main Methods:

  • Review and synthesis of existing literature on heterocyclic organic compounds in cancer chemotherapy.

Related Experiment Videos

  • Analysis of structure-activity relationships for various heterocyclic classes, including pyrrole, pyrimidine, indole, quinoline, and purine.
  • Categorization of modifications aimed at altering the reactivity and efficacy of antitumor agents.

    • Main Results:

    • Heterocyclic organic compounds, such as pyrrole, pyrimidine, indole, quinoline, and purine, have demonstrated significant potential.
    • These heterocycles exhibit interesting cytotoxicity profiles, making them valuable scaffolds for developing novel anticancer drugs.
    • Strategic modifications to these heterocyclic structures can enhance their reactivity and therapeutic effectiveness.

    Conclusions:

    • Heterocyclic organic compounds represent a crucial area for the development of novel and effective cancer chemotherapy agents.
    • Continued research into the modification and application of these compounds holds promise for advancing cancer treatment strategies.
    • The rational design and application of modified heterocycles are key to improving outcomes in the fight against neoplastic diseases.